Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127013
Filing Date
2024-11-14
Accepted
2024-11-14 16:01:23
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q drrx-20240930.htm   iXBRL 10-Q 1777677
2 EX-3.1 drrx-ex3_1.htm EX-3.1 7269
3 EX-10.3 drrx-ex10_3.htm EX-10.3 70364
4 EX-10.4 drrx-ex10_4.htm EX-10.4 501170
5 EX-31.1 drrx-ex31_1.htm EX-31.1 11861
6 EX-31.2 drrx-ex31_2.htm EX-31.2 11331
7 EX-32.1 drrx-ex32_1.htm EX-32.1 5788
8 EX-32.2 drrx-ex32_2.htm EX-32.2 6193
  Complete submission text file 0000950170-24-127013.txt   9044287

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20240930.xsd EX-101.SCH 1059265
65 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20240930_htm.xml XML 1808872
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 241461537
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)